查詢結果分析
來源資料
相關文獻
- Rare Metastases of Lung Adenocarcinoma to the Uterine Cervix and Retroperitoneal Lymph Nodes Resulting in Obstructive Uropathy, with a Good Response to Gefitinib
- Breast Metastasis from Lung Adenocarcinoma in a 26-year-old Woman: A Case Report
- Urologic Complications of Obstetrico-gynecologic Surgery: Experience from National Taiwan University Hospital
- 菸煙及油煙暴露與DNA修補酵素基因多形性對臺灣北部女性肺腺癌之交互作用
- Direct Involvement of Epstein-Barr Virus in Adenocarcinoma of the Lung
- Physiological Implications of Diuresis Renosonography in Clinically Suspicious Obstructive Uropathy
- Serum Sialyl Stage-Specific Embryonic Antigen Levels in Adenocarcinoma of the Lung
- CD44 Splicing Pattern is Associated with Disease Progression in Pulmonary Adenocarcinoma
- Correlation of in Vitro Chemosensitivity and Clinical Responses to Anticancer Drugs in Primary Adenocarcinoma of the Lung
- 肺癌關鍵突變基因之意義及檢測
頁籤選單縮合
題名 | Rare Metastases of Lung Adenocarcinoma to the Uterine Cervix and Retroperitoneal Lymph Nodes Resulting in Obstructive Uropathy, with a Good Response to Gefitinib=罕見的肺腺癌轉移至子宮頸及後腹腔淋巴結併阻塞性尿路病變,對gefitinib治療反應良好 |
---|---|
作者姓名(中文) | 陳俊榮; 楊宗穎; 張基晟; | 書刊名 | 胸腔醫學 |
卷期 | 27:6 2012.12[民101.12] |
頁次 | 頁357-362 |
分類號 | 416.224 |
關鍵詞 | 肺腺癌; 子宮頸轉移; 阻塞性尿路病變; 甲狀腺轉錄因子-1; 愛瑞莎; Lung adenocarcinoma; Uterine cervical metastasis; Obstructive uropathy; Thyroid transcription factor-1; Gefitinib; |
語文 | 英文(English) |
中文摘要 | 肺腺癌很少轉移至子宮頸。此外,肺腺癌也很少造成輸尿管阻塞。我們報告了一個肺腺癌轉移至子宮頸及後腹腔淋巴結併阻塞性尿路病變的個案。我們應用了免疫組織化學染色、表皮生長因子接受器基因及臨床病程來區分是肺腺癌或是子宮頸腺癌。在使用第一線gefitinib治療三個月後產生了極佳的反應。水腎及子宮頸轉移性腫瘤幾乎消失了。這是第一個個案報告描述gefitinib有效且安全地治療了肺腺癌轉移至後腹腔淋巴結併輸尿管阻塞。 |
英文摘要 | Lung adenocarcinoma with metastasis to the uterine cervix is rare, as is ureteral obstruction attributed to metastasis from lung adenocarcinoma. We report a case of lung adenocarcinoma with metastases to both the uterine cervix and retroperitoneal lymph nodes resulting in obstructive uropathy. We used immunohistochemical staining, the epidermal growth factor receptor gene and the clinical course to differentiate lung adenocarcinoma from cervical adenocarcinoma. An excellent response was achieved with first-line gefitinib treatment for 3 months-both the hydronephrosis and the metastatic cervical tumor had almost disappeared. This is the first case report of metastatic retroperitoneal lymphadenopathy with ureteral obstruction resulting from lung adenocarcinoma treated effectively and safely with gefitinib. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。